Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease

European Journal of Clinical Nutrition

Volumn 68, Issue 4, 2014, Pages 441-446

  Li, G ^a   Ren, J ^a   Wang, G ^a   Hu, D ^a   Gu, G ^a   Liu, S ^a   Ren, H ^a   Wu, X ^a   Li, J ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; SERUM ALBUMIN;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERIC FEEDING; ENTEROCUTANEOUS FISTULA; EXCLUSIVE ENTERAL NUTRITION; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; INFECTION RISK; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SEPSIS; TREATMENT DURATION; ABDOMINAL SURGERY; BODY MASS; INTESTINAL FISTULA; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICAL MODEL; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTESTINAL FISTULA; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897979834     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.16     Document Type: Article

References (29)

1. Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880.
2. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125: 1508-1530.
3. Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-Abdominal septic complications after a first ileocecal resection for Crohn's disease: A multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50: 331-336.
4. Iesalnieks I, Kilger A, Glass H, Mueller-Wille R, Klebl F, Ott C et al. Intraabdominal septic complications following bowel resection for Crohn's disease: Detrimental influence on long-Term outcome. Int J Colorectal Dis 2008; 23: 1167-1174.
5. Myrelid P, Olaison G, Sjodahl R, Nystrom P-O, Almer S, Andersson P. Thiopurine therapy is associated with postoperative intra-Abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009; 52: 1387-1394.
6. Yamamoto T, Allan RN, Keighley MRB. Risk factors for intra-Abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43: 1141-1145.
7. Heuschkel R. Enteral nutrition should be used to induce remission in childhood Crohn's disease. Dig Dis 2009; 27: 297-305.
8. Escher JC, Taminiau J, Nieuwenhuis EES, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: Best available evidence. Inflamm Bowel Dis 2003; 9: 34-58.
9. Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol 2012; 47: 872-882.
10. Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55: 558-562.
11. El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J et al. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease. Scand J Gastroenterol 2012; 47: 662-668.
12. Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn's disease: Is immunosuppressive medication associated with higher postoperative infection rates? Colorectal Dis 2011; 13: 1294-1298.
13. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12: 1730-1736.
14. Ali T, Yun L, Rubin DT. Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease. World J Gastroenterol 2012; 18: 197-204.
15. Liu S, Ren J, Gu G, Yuan Y, Han G, Wu Y et al. Drainage of intra-Abdominal abscesses with gastrointestinal fistula in Crohn's disease using a sump drain via trocar puncture: A modified strategy. Tech Coloproctol 2013; 17: 459-461.
16. Gu G, Ren J, Yuan Y, Chen J, Fan Y, Cao S et al. An innovative technique for intra-Abdominal abscess drainage using a sump drain by trocar puncture. Am Surg 2011; 77: E166-E167.
17. Wang G-f, Ren J-A, Liu S, Chen J, Wang X-b, Gu GS et al. Clinical characteristics of non-perianal fistulating Crohn's disease in China: A single-center experience of 184 cases. Chin Med J 2012; 125: 2405-2410.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170: 2-6.
19. Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003; 4: 1-18.
20. Keighley MRB, Heyen F, Winslet MC. Entero-cutaneous fistulas and Crohnsdisease. Acta Gastroenterol Belg 1987; 50: 580-600.
21. Brenner M, Clayton JL, Tillou A, Hiatt JR, Cryer HG. Risk factors for recurrence after repair of enterocutaneous fistula. Arch Surg 2009; 144: 500-505.
22. Van Assche G, Dignass A, Reinisch W, Van Der Woude CJ, Sturm A, De Vos M et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101.
23. Barbe L, Carbonnel F, Carrat F, Beaugerie L, Sezeur A, Gallot D et al. Effects of preoperative artificial nutrition in intestinal resections for Crohn disease. Gastroenterol Clin Biol 1996; 20: 852-857.
24. Smedh K, Andersson M, Johansson H, Hagberg T. Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn's disease. Eur J Surg 2002; 168: 154-157.
25. Guo Z, Li Y, Zhu W, Gong J, Li N, Li J. Comparing outcomes between side-To-side anastomosis and other anastomotic configurations after intestinal resection for patients with Crohn's disease: A meta-Analysis. World J Surg 2013; 37: 893-901.
26. Breese EJ, Michie CA, Nicholls SW, Williams CB, Domizio P, Walkersmith JA et al. The effect of treatment on lymphokine-secreting cells in the intestinal-mucosa of children with Crohns-disease. Aliment Pharmacol Ther 1995; 9: 547-552.
27. Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289.
28. Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004; 38: 270-275.
29. Kanazawa A, Yamana T, Okamoto K, Sahara R. Risk factors for postoperative intra-Abdominal septic complications after bowel resection in patients with Crohn's disease. Dis Colon Rectum 2012; 55: 957-962.